ALNFL.PA

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$15M	+66.7%	$-0.16	$-0.16–$-0.16	—	1
2027	$6M	-63.3%	$-0.24	$-0.24–$-0.24	—	1
2028	$18M	+218.2%	$0.59	$0.59–$0.59	—	1
2029	$39M	+120.6%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$0.08

Price

$0.82

Implied downside

-91%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
ALNFL.PANFL Biosciences S.A.	$0.81	-1.22%	$10M	—
AELIS.PAAelis Farma S.A.	$0.96	+1.05%	$13M	—
ALBIO.PABiosynex S.A.	$0.92	+0.00%	$17M	—
ALINS.PAIntrasense S.A.	$0.25	-0.00%	$13M	—
ALPAT.PAPlant Advanced Technologies S.A.	$4.28

NFL Biosciences S.A.

Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL Biosciences S.A. is a biotechnology enterprise dedicated to pioneering natural remedies for addiction cessation, particularly for individuals seeking to quit smoking. Their most advanced therapeutic candidate, NFL-101, derived from tobacco, is currently progressing through Phase III clinical trials specifically designed to combat smoking addiction. Additionally, the company's research pipeline features NFL-201, an extract blending cannabis and tobacco, and NFL-301, a botanical formulation rooted in traditional Chinese medicine, both of which are undergoing preclinical assessment.

www.nflbiosciences.com

Employees: 4
IPO / List date: Jul 5, 2021
HQ: FR

Held by traders on TradeandTell

No one on the platform currently holds ALNFL.PA.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ALNFL.PA as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ALNFL.PA yet.